E. Nalbat Et Al. , "Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma," EACR 2022 Annual Meeting , Sevilla, Spain, pp.3-4, 2022
Nalbat, E. Et Al. 2022. Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma. EACR 2022 Annual Meeting , (Sevilla, Spain), 3-4.
Nalbat, E., Tunçbağ, N., & Atalay, R., (2022). Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma . EACR 2022 Annual Meeting (pp.3-4). Sevilla, Spain
Nalbat, ESRA, NURCAN TUNÇBAĞ, And RENGÜL ATALAY. "Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma," EACR 2022 Annual Meeting, Sevilla, Spain, 2022
Nalbat, ESRA Et Al. "Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma." EACR 2022 Annual Meeting , Sevilla, Spain, pp.3-4, 2022
Nalbat, E. Tunçbağ, N. And Atalay, R. (2022) . "Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma." EACR 2022 Annual Meeting , Sevilla, Spain, pp.3-4.
@conferencepaper{conferencepaper, author={ESRA NALBAT Et Al. }, title={Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma}, congress name={EACR 2022 Annual Meeting}, city={Sevilla}, country={Spain}, year={2022}, pages={3-4} }